La anemia hemolítica autoinmune (AHAI) es una alteración hematológica autoinmune producida por la síntesis de autoanticuerpos contra los antígenos propios. Estas representam as formas mais comuns de anemia hemolítica hereditária. .. quanto ao seu potencial carcinogênico67 em relação à população pediátrica. Recibido para publicación: Aceptado para publicación: Introducción. La anemia hemolítica microangiopática se describió por prime-.

Author: Arat Goltirn
Country: Mozambique
Language: English (Spanish)
Genre: Video
Published (Last): 27 April 2010
Pages: 448
PDF File Size: 10.15 Mb
ePub File Size: 6.62 Mb
ISBN: 773-1-88478-710-8
Downloads: 52719
Price: Free* [*Free Regsitration Required]
Uploader: Tokree

Are you a health professional able to prescribe or dispense drugs? Annals of Pediatrics is the Body of Scientific Expression of the Association and is the vehicle through which members communicate.

CiteScore measures average citations received per document published.

Endocrine complications in patients with Thalassaemia Major. Neuroimaging Clin N Am.

Franchini M, Veneri D. Singh SP, Gupta S. Um novo quelante oral, o anema, foi recentemente aprovado nos EUA e no Brasil. Blood Cells Mol Dis.


The genetics of blood disorders: hereditary hemoglobinopathies

Birgens H, Ljung R. Moi P, Sadelain M. Sangre, 28pp. The anti-CD20 monoclonal antibody rituximab has gained widespread acceptance in the management of haematologic disorders with autoantibodies production.

The mechanism of action appears to be linked with the selective B-cell depletion and the lowering of autoantibody levels. Johnson C, Telen MJ. SRJ is a prestige metric based on the idea that not all citations are the same. Henolitica Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. Ann N Y Acad Sci.

There was a problem providing the content you requested

Chronic liver abnormalities in sickle cell disease: Predicting clinical severity in sickle cell anaemia. Thefirst child recovered spontaneously. Therefore, properly anmia clinical trials evaluating rituximab as salvage- and first-line-therapy for the treatment of AIHA and cold agglutinin disease are clearly warranted.

hrmolitica Fathallah H, Atweh GF. Carlos Gomes, cj. J Pediatr Rio J. Hematol Oncol Clin North Am. Services on Demand Journal.


Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Continuing navigation will be considered as acceptance of this use. Eur J Pediatr,pp. J Womens Health Larchmt. An update on anemia in less developed countries.

Correction of sickle cell disease by homologous recombination in embryonic stem cells. Human red blood cell polymorphisms and malaria. Established and experimental treatments for sickle cell disease. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.

Induction of fetal hemoglobin in the treatment of sickle pediatriq disease. Corticoids represent the andmia frontline therapeutic option for warm autoantibodies haemolytic anaemia. J Pediatr,pp.